Genmab — Januar 2018
-
Det må være i AQR long/short equity de tager deres shorts i Genmab https://funds.aqr.com/our-funds/alternative-investment-funds/long-short-equity-fund
-
Tesla en af deres største shorts. Gilead, Pfizer, Merck blandt de største longs.
-
Funden er lukket for nye investorer. Så de har så mange penge de ønsker i den
-
Siden funden startede i 2013 har der et afkast på 16,01% mod MSCI world på 9,82%.
-
Afkastet på 16,01% er p.a. Ganske godt må man sige.
-
3 ud af 4 Fund Managers har en Ph.D. fra MIT, Yale eller Carnegie Mellon
-
Helt hjernedøde er de nok ikke
-
Sukkeralf - tak for det.
-
E L - Do you really think that investors following Genmab on PI can affect the Genmab price more than a couple of hours? Well I don't. Furthermore I think it is interesting to do research on who you are up against!
-
Of course they will flip around when they are happy with their profit or they change view on Genmab. That's the purpose with investing...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind